doi: 10.3389/fcell.2022.844028 Received 27 December 2021 Accepted 21 January 2022 Published 17 February 2022 Volume 10 - 2022 Edited by Zhi-Gang Zhang, Shanghai Jiaotong University, China Reviewed by Jing Xue, Shanghai Jiao Tong University, China Yanli Zhang, University of Cambridge, United Kingdom Updates Copyright 2022 Deng, Guo, Du, Gu, Kong, Tao, Li and Fu
The interplay of activated immune cells, synovial cell hyperplasia, and cytokine fosters an osteoclastogenic environment fueled by TNF- and RANKL
10.1016/j.molmet.2020.101102 59 NeelandI
Adding Follistatin-344 for Myostatin Inhibition Follistatin-344 binds myostatin, the protein that limits muscle growth
This variability can lead to unnecessary dose adjustments, as some patients may be treated for perceived under-dosing although their anticoagulation therapy is effective